Dolutegravir-Based or Low-Dose Efavirenz–Based Regimen for the Treatment of HIV-1

Until mid-2018, the preferred initial antiretroviral therapy (ART) recommended in the World Health Organization (WHO) guidelines for human immunodeficiency virus type 1 (HIV-1) infection consisted of two nucleoside reverse-transcriptase inhibitors (NRTIs) combined with a nonnucleoside…

Leave a Reply

Your email address will not be published. Required fields are marked *